全球生物防禦市場（2023-2030）：規模、佔有率、成長分析以及按類型和應用分類的預測

Global Biodefense Market Size, Share, Growth Analysis, By Type(Anthrax, Smallpox), By Application(Hospitals and clinics, ambulatory care centres and others) - Industry Forecast 2023-2030

出版日期: 2023年10月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球生物防禦市場規模將從2021年的142.7億美元成長到2022年的150億美元，預測期內年複合成長率為5.1%，預計到2030年將達到223.3億美元。

近年來，由於生技藥品的威脅日益增加以及對有效準備和應對措施的需求，全球生物防禦市場經歷了顯著的成長和轉型。生物防禦是指旨在應對與生物恐怖主義、流行病和其他生物緊急情況相關的潛在風險的各種活動和技術，這個市場包括疫苗、治療、檢測和診斷、防護工具等多種領域。

人們對生物攻擊和集體爆發造成的潛在災難的認知不斷增強，導致對生物防禦解決方案的需求激增。世界各國政府正對生物防禦能力進行大量投資，推動市場成長。此外，技術進步和對研發的日益關注也導致了創新和複雜的生物防禦產品的推出。基因組學、合成生物學和資料分析等技術的進步增強了生物威脅的檢測、表徵和緩解能力，並推動了生物防禦解決方案的發展。此外，政府、國防機構和私人企業之間的合作也促進了綜合生物防禦戰略的發展並支持市場擴張。

該報告調查了全球生物防禦市場，並提供了市場概況、市場各種影響因素分析、技術和創新趨勢、法律制度、市場規模趨勢和預測，以及按各個細分市場和地區進行的競爭。形勢、主要企業簡介等

執行摘要
調查方法
母市場分析
- 市場概況
- 市場規模
- 市場動態
  - 促進因素
  - 機會
  - 抑制因素
  - 任務
關鍵市場洞察
- 技術分析
- 價格分析
- 供應鏈分析
- 價值鏈分析
- 市場生態系統
- 智慧財產權分析
- 貿易分析
- 啟動分析
- 原料分析
- 創新矩陣
- 研發線產品分析
- 總體經濟指標
- 重點投資分析
- 關鍵成功因素
- 競爭程度
- 市場動態及展望
  - 市場動態
    - 促進因素
    - 機會
    - 抑制因素
    - 任務
- 法規狀況
- 波特的分析
- Skyquest 對未來顛覆的獨家見解
全球生物防禦市場：按類型
- 市場概況
- 炭疽菌
- 天花
- 肉毒中毒
- 輻射/核能
- 其他
全球生物防禦市場：依應用分類
- 市場概況
- 醫院/診所
- 門診治療中心
- 其他
全球生物防禦市場：按地區
- 市場概況
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東/非洲
競爭形勢
- 前5名企業對比
- 主要企業市場地位
- 主要企業的招募策略
- 關鍵成功策略
- 近期市集活動
- 主要企業市場佔有率
主要企業簡介
- XOMA Corporation
- Altimmune Inc.
- Emergent Biosolutions Inc.
- Dynavax Technologies Corporation
- SIGA Technologies
- Elusys Therapeutics Inc.
- Ichor Medical Systems
- Dynport Vaccine Company
- Cleveland Biolabs
- Bavarian Nordic
- Ology Bioservices
- Alnylam Pharmaceuticals Inc.
- Evolva
- BioCryst Pharmaceuticals Inc.
- PharmAthene Inc.
- Profectus Biosciences Inc.
- NanoViricides Inc.
- Takeda Pharmaceutical Company Limited
- Sanofi Pasteur
- GlaxoSmithKline

簡介目錄

Product Code: SQMIG35H2102

Global Biodefense Market size was valued at USD 14.27 billion in 2021 and is poised to grow from USD 15 billion in 2022 to USD 22.33 billion by 2030, growing at a CAGR of 5.1% during the forecast period (2023-2030).

The global biodefense market has witnessed significant growth and transformation in recent years, driven by the increasing threats posed by biological agents and the need for effective preparedness and response measures. Biodefense refers to a range of activities and technologies aimed at countering the potential risks associated with bioterrorism, pandemics, and other biological emergencies. The market encompasses various sectors, including vaccines, therapeutics, detection and diagnostics, and protective equipment. The demand for biodefense solutions has surged due to the growing recognition of the potential catastrophic consequences of biological attacks and outbreaks. Governments around the world are investing heavily in biodefense capabilities, bolstering the market's growth. Additionally, advancements in technology and the increasing focus on research and development have led to the introduction of innovative and sophisticated biodefense products. Technological advancements, including genomics, synthetic biology, and data analytics, are driving the evolution of biodefense solutions, providing enhanced capabilities in detection, characterization, and mitigation of biological threats. Furthermore, collaborations between governments, defense agencies, and private sector entities have fostered the development of comprehensive biodefense strategies and bolstered market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Biodefense Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biodefense Market Segmental Analysis

Global Biodefense Market is segmented by type, application, and region. Based on type, the market can be segmented into Anthrax, Smallpox, Botulism, Radiation/Nuclear and Others. Based on application, the market is segmented into Hospitals and clinics, ambulatory care centres and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Biodefense Market Dynamics

Drivers of the Global Biodefense Market

Increasing recognition of the potential catastrophic consequences of biological threats

One key driver of the global biodefense market is the increasing recognition of the potential catastrophic consequences of biological threats. Governments, defense agencies, and healthcare organizations worldwide are investing heavily in biodefense capabilities to mitigate the risks posed by bioterrorism, pandemics, and other biological emergencies.

Restraints in the Global Biodefense Market

High costs associated with research and development of biodefense solutions

A notable restraint for the Global Biodefense Market is the high costs associated with research and development of biodefense solutions. Developing effective vaccines, therapeutics, and detection systems requires substantial investment in research, clinical trials, and regulatory approvals. The complex nature of biodefense threats adds to the challenges, making it difficult to achieve cost-effective solutions and hindering market growth.

Market Trends of the Global Biodefense Key

One key market trend in the global biodefense market is the increasing focus on the development of advanced diagnostic technologies. There is a growing emphasis on the rapid and accurate detection of biological agents to enable early intervention and effective response during biodefense incidents. Innovative diagnostic tools, such as point-of-care testing devices and molecular diagnostics, are being developed to enhance the speed and accuracy of identifying potential biological threats. This trend aims to strengthen surveillance systems and improve the overall preparedness and response capabilities in biodefense scenarios.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Biodefense Market by Type
- Market Overview
- Anthrax
- Smallpox
- Botulism
- Radiation/Nuclear and Others
Global Biodefense Market by Application
- Market Overview
- Hospitals and clinics
- ambulatory care centres and others
Global Biodefense Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- XOMA Corporation (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Altimmune Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Emergent Biosolutions Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Dynavax Technologies Corporation (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- SIGA Technologies (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Elusys Therapeutics Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Ichor Medical Systems (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Dynport Vaccine Company (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Cleveland Biolabs (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bavarian Nordic (Denmark)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Ology Bioservices (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Alnylam Pharmaceuticals Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Evolva (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BioCryst Pharmaceuticals Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- PharmAthene Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Profectus Biosciences Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- NanoViricides Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Takeda Pharmaceutical Company Limited (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sanofi Pasteur (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- GlaxoSmithKline (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments